AdvaMed Unveils State-Based Competitiveness Agenda

AdvaMed and the State Medical Technology Alliance, including MedTech, released a comprehensive policy agenda focused on state-based initiatives that will foster an environment of growth and patient access to the latest in medical innovation.
By: MedTech Association
Spread the Word
Listed Under

Medical Technology
Research And Development
Medical Device
Healthcare Reform


Syracuse - New York - US


Feb. 5, 2013 - PRLog -- WASHINGTON, D.C.– The Advanced Medical Technology Association (AdvaMed), in conjunction with the State Medical Technology Alliance (SMTA) today released a comprehensive state-based policy agenda aimed at preserving America’s global leadership in medical innovation.

AdvaMed’s SMTA is a network of state-based industry associations including MedTech, the hub of Upstate New York’s Bio/Med industry. Building on AdvaMed’s federal-level Competitiveness Agenda launched in 2011, the association’s new State Medical Technology Competitiveness Agenda outlines policy options states should adopt in order to foster an environment of growth and patient access to the latest in medical innovation.

“America’s medical technology companies support two million jobs nationwide. The U.S. is the global leader in the development of medical technology but that leadership is eroding. And yet, there are positive steps states can take to attract companies and, at the same time, improve patient access to life-enhancing technologies,” said Stephen J. Ubl, president and CEO of AdvaMed.

Growth of the medical technology industry tends to center around clusters of excellence, in which start-ups generate technologies of the future, medical centers and universities contribute ideas and trained personnel, and larger firms interact with the start-ups to help transform new products into large scale sales and employment.

The state-based agenda is focused on creating a more favorable business climate and increased predictability for promising early-stage companies as well as established firms. The agenda proposes specific recommendations under three broad policy areas including: state taxes, business assistance programs, and coverage and reimbursement policies. Specific recommendations include:

Research and development tax credits and state-run venture capital funds should be established by states that have not already done so, providing a significant boost for start-ups in particular.

States should consider tax credits to mitigate the impact of the federal medical device excise tax, which took effect on Jan. 1 since the federal tax will have a negative impact on industry employment as well as research and development.

Work force training grants should be provided to meet manufacturers’ needs for employees with unique skills and training for medical device manufacturing positions.  Grants could fund programs administered by state life science associations.

Reimbursement policies under state Medicaid plans, as well as state employee insurance and workers’ compensation programs, should ensure patients have timely and predictable access to innovative medical technologies.

“AdvaMed’s State Medical Technology Competitiveness Agenda will help states retain and attract the kind of high-paying, high tech jobs that will fuel America’s economy in the 21st century,” Ubl said. “We look forward to working with SMTA and state policymakers to implement these proposals and ensure the U.S. retains its competitive edge in medical innovation,” said Ubl.

“New York is one of the leading states for business and research in the bioscience and medical technology industry,” said Jessica Crawford, president of MedTech. “Our focus on benefits that will make our Bio/Med companies competitive on a national and global scale will also contribute to business growth, which ultimately leads to more jobs and economic growth.”

Full details of the AdvaMed State Medical Technology Competitiveness Agenda and additional background information on the Agenda can be found at

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit

MedTech is an active association of pharmaceutical, biotech, and medical technology companies, their suppliers and service providers, and research universities. We boost the growth and prosperity of our members by connecting them for collaboration, offering educational programs, sharing news and information, and advocating for the industry with government and leaders. For more information, visit
Email:*** Email Verified
Tags:Medical Technology, R D, Research And Development, Medical Device, Healthcare Reform
Industry:Medical, Government
Location:Syracuse - New York - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
MedTech PRs
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share